The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.
about
Validation of a Multiplexed Gene Signature Assay for Diagnosis of Canine Cancers from Formalin-Fixed Paraffin-Embedded TissuesThe innate immune response in fetal lung mesenchymal cells targets VEGFR2 expression and activity.Cross-species analysis of the canine and human bladder cancer transcriptome and exome.
P2860
The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@ast
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@en
type
label
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@ast
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@en
prefLabel
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@ast
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@en
P2093
P2860
P1433
P1476
The c-MET Network as Novel Pro ...... Developing Aggressive Disease.
@en
P2093
Chunri Yan
Jayoung Kim
Phildu Jeong
Sang Keun Lee
Seok Joong Yun
Seon-Kyu Kim
Seon-Young Kim
Sung Phil Seo
Wun-Jae Kim
Young-Won Kim
P2860
P304
P356
10.1371/JOURNAL.PONE.0134552
P407
P577
2015-07-30T00:00:00Z